Naratriptan Inteli (Naratriptan Hydrochloride)

Naratriptan works by selectively activating 5‑HT1B and 5‑HT1D serotonin receptors located on cranial blood vessels and trigeminal nerve endings. This activation causes constriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and providing relief.

The specific dose and dosing schedule for Naratriptan Inteli are determined by the prescribing healthcare professional based on the individual patient's medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of naratriptan during pregnancy and lactation has not been definitively established, and the product is classified with an unknown pregnancy category. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any required import documentation.

Naratriptan has a longer half‑life than many other triptans, which can provide sustained relief and reduce the need for repeat dosing. Its onset of action is moderate, and it is generally well tolerated, but individual response varies, so clinicians may choose based on patient history, cardiovascular risk, and previous triptan experience.

Naratriptan Inteli should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Naratriptan Inteli is taken orally, usually as a tablet, with or without water. It is recommended to take the medication as soon as migraine symptoms begin. Patients should not exceed the maximum daily dose prescribed by their healthcare professional.

Serious risks include cardiovascular events such as chest pain, myocardial infarction, and severe hypertension, especially in patients with underlying heart disease. Additionally, serotonin syndrome can occur if combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience these symptoms.

Naratriptan Inteli is contraindicated in patients with a history of coronary artery disease, uncontrolled hypertension, peripheral vascular disease, or severe hepatic impairment. It should also be avoided in individuals who have taken MAO inhibitors within the past two weeks or who are currently using other triptans or ergotamine derivatives.